Fintech ‘unicorn’ Numbrs slashes jobs as investors turn tail
Numbrs has a custom-made premises in Zurich to house its HQ.
All Rights Reserved
The mobile banking app Numbrs is poised to cut 62 of its Zurich-based staff after investors pulled out of an agreement to inject new funds into the company. Just last year, the fintech firm said it was worth CHF1 billion having attracted big ticket investments from around the world.
This content was published on
2 minutes
When not covering fintech, cryptocurrencies, blockchain, banks and trade, swissinfo.ch's business correspondent can be found playing cricket on various grounds in Switzerland - including the frozen lake of St Moritz.
The digital finance platform employs around 150 staff at its headquarters in Zurich. Operating mainly in the German market, Numbrs had raised $200 million (CHF195 million) in previous funding rounds despite failing to make an annual profit since its inception in 2014.
But the company now faces a painful restructuring period because “a new round of financing in the high double-digit million range has not materialized despite a legally binding signature”. The company did not name the proposed investors or say whether they had pulled out due to the economic uncertainties created by coronavirus.
As a result of the blow, Numbrs says it must now reduce fixed costs, such as staff wages, by 50%. But the company is going ahead with plans to enter the British market.
“I would like to ask all Numbrs employees for understanding that, like many other startups, we now have to prepare for a longer dry spell,” stated managing partner Fynn Kreuz.
The coronavirus pandemic has negatively impacted venture capital funding as the economy and financial markets have been thrown into turmoil. Several investors have seen their own wealth shrink and are concentrating on keeping their current portfolio of start-ups afloat rather than risking new investments.
Swiss study: Arabica cultivation areas could be halved by 2050
This content was published on
Around the world, the areas most suitable for growing the bean could even shrink by 60% if greenhouse gas emissions remain high.
This content was published on
The UN Human Rights Council approved the launch of this mechanism in Geneva on Friday, to be followed by an International Commission of Inquiry.
More than 100 wolves shot in Switzerland last year
This content was published on
Swiss hunters legally killed 101 wolves between February 1, 2024, and the end of January 2025. A further six died in accidents or from natural causes.
Swiss health office turns to Bluesky against backdrop of US censorship
This content was published on
The Swiss Federal Office of Public Health (FOPH) has joined the Bluesky social network, while US President Donald Trump works with X owner Elon Musk to censor content on official US websites.
Biotech company BioVersys is first Swiss IPO of 2025
This content was published on
The Basel-based biotech company BioVersys made the first initial public offering (IPO) of the year in Switzerland on Friday.
Much more spent on Swiss motorway vote campaigns than budgeted
This content was published on
Opponents and supporters of motorway expansion spent over CHF10 million ($11 million) on their campaigns, around a third more than announced in November.
Swiss researchers monitor animal populations with AI microphone
This content was published on
Researchers in Lausanne are using an intelligent microphone to make the animal world audible. The microphone automatically records animal sounds over large areas and analyses them using AI.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss fintech scene on the verge of a ‘big decade’
This content was published on
The number of financial technology start-ups is rapidly growing in Switzerland, as is the amount of funding they receive from venture capitalists.
Swiss venture capital funding breaks CHF2 billion barrier
This content was published on
New ventures in the ICT and fintech sectors received the largest slice of funding (CHF1.2 billion), but financial support for early stage biotech firms also received a significant boost (CHF625 million), according to the annual reportExternal link from online news portal startupticker.chExternal link and the investor association SECAExternal link. Four Swiss companies – ADC Therapeutics,…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.